Library — CHDR

Search

Filter

The effects of a glycine reuptake inhibitor R231857 on the central nervous system and on scopolamine-induced impairments in cognitive and psychomotor function in healthy subjects.

Liem-Moolenaar M, Zoethout RW, de Boer P, Schmidt M, de Kam ML, Cohen AF, Franson KL, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2010 Oct; 24(11):1681-7

View publication
Pharmacokinetics, pharmacodynamics and the pharmacokinetic/ pharmacodynamic relationship of zolpidem in healthy subjects.

de Haas SL, Schoemaker RC, van Gerven JM, Hoever P, Cohen AF, Dingemanse J

Journal of psychopharmacology (Oxford, England), 2010 Oct; 24(11):1619-29

View publication
Method development studies for repeatedly measuring anxiolytic drug effects in healthy humans.

Klumpers F, van Gerven JM, Prinssen EP, Niklson I, Roesch F, Riedel WJ, Kenemans JL, Baas JM

Journal of psychopharmacology (Oxford, England), 2010 Apr; 24(5):657-66

View publication
Inhibition of THC-induced effects on the central nervous system and heart rate by a novel CB1 receptor antagonist AVE1625.

Zuurman L, Roy C, Schoemaker RC, Amatsaleh A, Guimaeres L, Pinquier JL, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2010 Feb; 24(3):363-71

View publication
Psychomotor and cognitive effects of a single oral dose of talnetant (SB223412) in healthy volunteers compared with placebo or haloperidol.

Liem-Moolenaar M, Gray FA, de Visser SJ, Franson KL, Schoemaker RC, Schmitt JA, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2009 Dec; 24(1):73-82

View publication
Pharmacodynamic and pharmacokinetic effects of the intravenously administered CB1 receptor agonist Org 28611 in healthy male volunteers.

Zuurman L, Passier PC, de Kam Ml, Kleijn HJ, Cohen AF, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2009 Jul; 23(6):633-44

View publication
The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers.

de Haas SL, Franson KL, Schmitt JA, Cohen AF, Fau JB, Dubruc C, van Gerven JM

Journal of psychopharmacology (Oxford, England), 2009 Jul; 23(6):625-32

View publication
Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum.

Bossong MG, van Berckel BN, Boellaard R, Zuurman L, Schuit RC, Windhorst AD, van Gerven JM, Ramsey NF, Lammertsma AA, Kahn RS

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2009 Jan; 34(3):759-66

View publication
Biomarkers for the effects of cannabis and THC in healthy volunteers.

Zuurman L, Ippel AE, Moin E, van Gerven JM

British journal of clinical pharmacology, 2008 Dec; 67(1):5-21

View publication

«
1
2
3
4
5
6
7
8
9
10
11
»